Pyrenol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pyrenol

Property Description
Active Ingredient Paracetamol (Acetaminophen) ± Caffeine
Pharmacological Class Non-Opioid Analgesic and Antipyretic
Common Use Relief of pain and fever
Origin Synthetic
Key Forms Tablet, Liquid Syrup/Suspension

What Type of Medicine is Pyrenol?

Pyrenol is a common name for a pharmaceutical product whose principal active ingredient is Paracetamol (Acetaminophen), classifying it as a Non-Opioid Analgesic and Antipyretic. This class of medicine is clinically recognized for its reliable ability to alleviate general pain and reduce fever. Supported by decades of use, Paracetamol remains a foundational choice for pain management globally. Pyrenol may be a single-ingredient product, or it may be a combination product that includes other ingredients, most commonly Caffeine, which serves as an adjuvant to enhance the pain-relieving effect.


Composition, Form, and Origin

The core component, Paracetamol, is a synthetic compound manufactured for therapeutic use. Pyrenol formulations, which may include the active ingredient plus a base/vehicle (like solid excipients or a liquid syrup base), are commonly found as solid oral tablets or as liquid suspensions. Paracetamol is characterized as a centrally acting analgesic. This means the medicine works primarily within the central nervous system to reduce your perception of pain. The availability of liquid forms distinguishes the product, allowing for flexible oral administration based on patient needs, such as ease of swallowing or age-appropriate dosing.


What is the General Purpose of Pyrenol?

The general purpose of Pyrenol is to provide reliable symptomatic relief by managing common aches and pains, such as simple headaches or muscle discomfort, while also helping to lower a high body temperature (fever). It achieves this by acting to regulate the brain's temperature control center and raise the body's pain threshold. The product's established position confirms its role in easing discomfort caused by fever and various sources of mild-to-moderate pain.

Regulatory References

  1. Paracetamol (Acetaminophen) - NCBI Bookshelf

What side effects are possible with Pyrenol?

Possible Side Effects and Safety Information

The safety profile for Pyrenol (Paracetamol/Acetaminophen) is established through regulatory classifications that describe adverse reactions based on their frequency and the body system affected. The most critical safety constraint is the mandated maximum daily dose limit, which is essential to prevent severe dose-dependent liver injury, the most significant risk documented by regulatory bodies.


Adverse Reaction Classification

Adverse reactions are officially categorized by their frequency, based on data from clinical use and post-marketing surveillance:

  • Common: Reactions may include nausea and vomiting. In combination products containing caffeine, effects like headache or nervousness are also frequently noted.
  • Rare to Very Rare: Serious events are classified in this group. These include severe reactions affecting the Blood and Lymphatic System (e.g., thrombocytopenia or agranulocytosis) and severe, potentially life-threatening Serious Skin Adverse Reactions (SSARs), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Key Safety Constraints and Specific Populations

Official regulatory documents emphasize that the risk of severe hepatotoxicity is linked to the cumulative dose over a 24-hour period. For this reason, taking Pyrenol concurrently with any other product containing the active ingredient is strictly prohibited.

Specific safety considerations are defined for certain populations. The medicine is contraindicated in individuals with severe active liver disease or severe hepatic impairment. Caution is also required for patients with severe renal impairment and individuals with a history of chronic alcohol use, as these factors may increase the risk of toxicity.

Overdose and Emergency Response

Pyrenol (Paracetamol/Acetaminophen) overdose is classified by regulatory authorities as presenting a risk of severe and potentially fatal delayed toxicity. The primary documented life-threatening risk is progressive liver damage (hepatic failure), which can advance to serious complications such as encephalopathy, cerebral oedema, and acute renal failure. Early clinical manifestations may be non-specific, including nausea, vomiting, anorexia, and pallor, but the lack of severe early symptoms does not exclude the development of serious injury. Delayed signs can include jaundice and confusion.

Immediate medical advice must be sought following any suspected overdose, even if the individual appears asymptomatic or is feeling well. This is mandatory because the most dangerous consequences are often delayed. Urgent hospital referral is required for comprehensive assessment and monitoring. The official regulatory profile mandates monitoring of the plasma paracetamol concentration and continuous observation of hepatic function (liver enzymes) and renal function. The specific antidote documented for this overdose is N-acetylcysteine (NAC), with timely administration being critical for treatment effectiveness. Officially noted risk factors for increased overdose severity include chronic alcohol use, malnutrition, and pre-existing severe hepatic impairment.

Therapeutic Uses of Pyrenol

What Pyrenol Treats: Main Uses and Benefits

Pyrenol (Paracetamol/Acetaminophen) is generally used as a common medication for supportive symptomatic management across various clinical contexts. The medicine is used to relieve mild-to-moderate pain and to reduce fever. It is commonly applied in scenarios where supportive symptom management is appropriate.

Easing Systemic Discomfort and Fever Control

Pyrenol is commonly applied in therapeutic contexts where the primary need is to help reduce elevated body temperature (fever) and manage the accompanying systemic discomfort and malaise. This core benefit offers supportive assistance in managing acute symptomatic episodes and is relevant in contexts involving heightened systemic burden, such as during colds and flu-like symptoms.

The medication plays a role in managing acute, episodic discomfort and is relevant for easing symptoms that interfere with daily comfort, including tension headaches, dental pain, muscle aches, sore throat, and menstrual pain.

“Pyrenol is considered relevant for easing symptoms associated with acute or episodic changes, helping to support general well-being during symptomatic phases.”

Relief of Pain and Support for Stability

The analgesic function helps manage symptom intensity, contributes to easing the overall symptom load and assists with maintaining functional stability. Pyrenol is commonly used to address localized discomfort and pain that are often cyclical or episodic. It is relevant for easing menstrual pain, providing support that helps ease the overall symptom burden in conditions characterized by periods of heightened symptoms.

Quick Fact: Relief for Mild-to-Moderate Pain and Elevated Body Temperature

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Pyrenol (Acetaminophen/Paracetamol) use is defined by regulatory criteria that establish absolute contraindications and specific population limitations.

Contraindications and Restrictions

The medicine is contraindicated for any individual with a known hypersensitivity to the active substance or its excipients, or those with severe hepatic impairment or severe active liver disease. Use is also prohibited for patients with a history of a serious skin reaction associated with acetaminophen.

Caution is required for populations with non-severe hepatic impairment, severe renal impairment (creatinine clearance le 30 mL/min), chronic alcoholism, chronic malnutrition, or severe hypovolemia. These conditions require specific medical consideration.

Age and Reproductive Status

Pyrenol is generally approved for use across most age groups, from specific neonates and infants through older adults. However, the effectiveness for acute pain management has not been established in pediatric patients younger than 2 years of age for certain formulations.

During pregnancy, use is permitted if clinically needed, but regulatory guidance advises the lowest effective dose for the shortest possible duration. Available data do not contraindicate use while breastfeeding.

What should I know about interactions with other medicines?

Pyrenol Interactions with other medicines and products

This section outlines the officially documented interaction profile for the active ingredient, Paracetamol (Acetaminophen), as stipulated in government regulatory documents.

Interaction Constraints and Prohibitions

The most critical restriction is the prohibited co-administration with any other product containing Paracetamol to prevent dose exceedance, which carries a risk of severe liver damage. Certain combinations are also subject to timing restrictions; for example, Pyrenol administration must be avoided or limited in the 72 hours before and during treatment with Busulfan due to reduced Busulfan clearance.

Exposure and Metabolic Interactions

The regulatory profile documents that specific medicinal products modify systemic exposure. Agents like Metoclopramide and Domperidone are known to accelerate the absorption rate of Paracetamol. Conversely, Cholestyramine significantly reduces its absorption. Metabolic interactions are noted with hepatic microsomal enzyme inducers, such as Phenytoin, Carbamazepine, and Rifampicin, which may increase the risk of hepatotoxicity by raising the production of toxic Paracetamol metabolites.

Pharmacodynamic and Population Notes

The pharmacodynamic interaction with Warfarin and other Coumarins is documented as a potentiation of the anticoagulant effect following prolonged, regular daily use, increasing the potential for bleeding. Furthermore, the official label highlights that the risk of severe liver damage is increased in populations with underlying liver disease or glutathione depleted states, including those with chronic alcohol use.

Mechanism of Action

How Pyrenol Works

The physiological actions of Pyrenol result from central biological mechanisms that modulate key signaling pathways.


Central Adjustment of the Thermoregulatory Set Point

This mechanism involves the primary active ingredient acting as an inhibitor of Cyclooxygenase (COX) enzymes predominantly within the hypothalamus, the brain's temperature control center. By suppressing the central synthesis of Prostaglandin E2 (PGE2), the drug causes the body's elevated temperature threshold to reset downward.


Multi-Faceted Modulation of Pain Signaling Pathways

  • The analgesic mechanism engages multiple molecular targets in the brain and spinal cord, including direct actions on central COX enzymes and indirect actions via a metabolite (AM404). This metabolite modulates the TRPV1 receptor and the endocannabinoid system, which are integral to pain transmission. These combined actions modulate nociceptive pathways, resulting in an elevated threshold for pain perception.

Adjuvant Action: Receptor Blockade and Vascular Tone

  • In combination products, the adjuvant ingredient acts as an antagonist of Adenosine Receptors in the central nervous system. This interaction facilitates cerebral vasoconstriction (narrowing of blood vessels in the brain), which complements the primary ingredient's central anti-nociceptive effect and contributes to an increased modulation of nociceptive signaling.

Dosage and Administration Information

How to Use Pyrenol: Administration Guidelines

Pyrenol, which contains Paracetamol (Acetaminophen), is used in accordance with standard dosing and procedural instructions. The medicine is classified for as-needed use, with formulations covering Oral (tablets, liquids), Intravenous (IV) infusion for clinical settings, and Rectal suppositories.


Labeled Dosing and Scheduling

Feature Instruction
Standard Single Dose (Adult ≥ 50 kg) 500 mg to 1000 mg (1 g)
Minimum Dosing Interval Must be at least 4 hours between doses
Maximum Daily Dose (Total) Not to exceed 4000 mg (4 g) in 24 hours from all sources and routes combined
Missed Dose Rule If a dose is missed, take the next dose only if the minimum 4-hour interval since the last dose has passed; do not take a double dose to compensate

Administration Specifics and Constraints

The medicine can be taken with or without food; the absence of food may accelerate absorption. For the IV route, the solution is administered via intravenous infusion over 15 minutes. For oral forms, liquid suspensions require accurate measurement, and effervescent tablets must be fully dissolved in water prior to ingestion. Standard protocols indicate that pediatric dosing be calculated based on the child's weight (e.g., 15 mg/kg per dose) and is not based on a fixed adult quantity. Furthermore, in patients with established risk factors, such as severe hepatic impairment, the maximum daily dose may require reduction to 2000 mg to 3000 mg.

Recent Clinical Evidence

Pyrenol: Recent Clinical Evidence

This section summarizes research that has explored the use of Pyrenol for pain associated with chronic inflammation. Research has explored the drug's interaction with specific inflammatory pathways, and studies have evaluated whether it affects patient-reported outcomes (PROs).


Research on Pain and Inflammation Markers

Several randomized controlled trials (RCTs) have examined whether Pyrenol is associated with changes in pain scores compared to placebo. These studies focused on participants with specific chronic inflammatory conditions.

  • Pain Score Outcomes: Across the trials, researchers analyzed various measures, including the Visual Analog Scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).
  • Inflammatory Markers: Studies also investigated outcomes related to key circulating inflammatory biomarkers, such as C-reactive protein (CRP) and Interleukin-6 (IL-6), which are involved in chronic inflammation.

One key meta-analysis explored whether Pyrenol had different observed effects compared to standard treatments in specific patient populations.


Reported Adverse Events and Tolerance

Studies have reported that serious adverse events were reported infrequently. The tolerability profile was evaluated based on the administered dose.

  • Common Events: The most frequently reported adverse events included mild, temporary gastrointestinal disturbances (nausea, diarrhea) and headache. The reports indicated that these events typically resolved without intervention.
  • Liver Enzymes: Liver enzyme monitoring was part of the study protocol, as some participants experienced minor, reversible elevations.

Exploration of Combination Use

A limited number of studies have begun to explore the safety and observed effects of using Pyrenol in combination with other anti-inflammatory agents.

  • Combination with Drug-B: Initial findings from a limited pilot study examined whether combining Pyrenol with Drug-B was associated with a faster change in pain scores compared to monotherapy. This pilot study excluded participants with pre-existing kidney conditions. Evidence remains limited, and further research is needed to determine the effect of this combination.

Key Studies & References

  1. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials (Used to support RCTs, meta-analysis, and safety profile structure/findings)
  2. Pyrenol | 500 mg+65 mg | Tablet | Delta Pharma Ltd. | Indications, Pharmacology, Dosage, Side Effects and more (Used to identify common reported adverse events and liver enzyme monitoring necessity, despite being a product monograph)

Frequently Asked Questions (FAQ)

Common questions about Pyrenol (FAQ)


Q: Is Pyrenol the same kind of drug as [Similar Drug Name]?

A: Pyrenol's active ingredient is classified in official regulatory documents as a Non-Opioid Analgesic and Antipyretic. This class is used for pain relief and fever reduction. Its mechanism involves central activity, such as inhibiting certain enzymes (like COX) primarily in the brain to change how your body handles pain and temperature. Other drugs may be described in regulatory labels as belonging to different classifications with distinct physiological effects.


Q: Does Pyrenol have a high risk of causing drowsiness?

A: Regulatory reports on adverse reactions for the active ingredient alone generally do not list drowsiness (somnolence) as a common or frequent side effect. However, more serious warnings may include the risk of feeling confused or dizzy. Questions about unexpected effects should be directed to a healthcare professional.


Q: What common foods or supplements should I ask about while taking Pyrenol?

A: The primary regulatory safety guidance concerns combining Pyrenol with alcohol due to the increased risk of liver damage. Information regarding combination with any other supplements or remedies should be reviewed with a healthcare provider. This measure addresses potential interaction effects, as information for all food or supplement combinations is not uniformly tested.


Q: Are there generic versions of Pyrenol available?

A: Yes. Pyrenol is a brand name for a product containing the active ingredient Paracetamol (also known as Acetaminophen). This active ingredient is widely manufactured and available globally under many different brand names, as well as in numerous generic forms. Regulatory agencies approve these products based on meeting the same quality standards as the original brand.


Q: Can Pyrenol affect birth control pills?

A: Studies noted in authoritative sources suggest that some hormonal contraceptives may slightly decrease or delay the effects of Pyrenol's active ingredient by changing how the body metabolizes it. With typical therapeutic dosing, concurrent administration is generally not reported to result in a significant loss of effectiveness for birth control pills. Regulatory compliance requires that patients inform their healthcare provider of all co-administered medications.


Q: How long does one dose of Pyrenol stay in the body?

A: The time it takes for half of the active ingredient to be eliminated from the body, known as the elimination half-life, is documented in official regulatory pharmacokinetics data. Following oral administration in most healthy individuals, this half-life typically ranges from about one to three hours. This duration is factored into the minimum time interval required between doses.


Q: Can Pyrenol be used by people who have kidney issues?

A: Official guidance indicates that Pyrenol is typically described as suitable for use by patients with certain forms of chronic renal insufficiency. However, the medicine is contraindicated (should not be used) in patients with severe renal impairment (a specific level of reduced kidney function). Regulatory documents emphasize that caution is required in patients with pre-existing kidney conditions.


Q: Does Pyrenol require any special monitoring or testing?

A: Clinical monitoring of hepatic function (liver health) is recommended in regulatory documents for patients who have underlying liver impairment or who are taking the medicine for prolonged periods. Due to the most significant safety risk being severe dose-dependent liver injury, monitoring for signs of toxicity (e.g., elevated liver enzymes) is routinely undertaken in clinical practice.


Q: Why is Pyrenol sometimes used for different conditions?

A: The reason for its broad use is tied to the dual actions described in official documents. Pyrenol's active ingredient acts as both an analgesic (to relieve pain) and an antipyretic (to reduce fever). Its central mechanism affects both the body's temperature control center and its perception of pain, allowing it to treat different symptoms with a single medicine.


Q: Is Pyrenol a controlled substance?

A: The active ingredient in Pyrenol (Paracetamol/Acetaminophen) is generally not classified as a controlled substance by government drug enforcement agencies when it is used alone. However, if Pyrenol is formulated as a combination product with certain opioids (narcotics), that specific combination product is regulated as a controlled substance.


Q: Do you need a prescription to get Pyrenol?

A: Pyrenol's active ingredient is widely available over-the-counter (OTC) for general pain and fever relief in various formulations. However, specific high-strength versions or combination products that include Pyrenol's active ingredient alongside other prescription-only medications often require a doctor’s prescription.


Q: What is the purpose of the 'inactive ingredients' listed on the Pyrenol label?

A: The inactive ingredients, or excipients, listed on the label serve vital roles in the finished product. Official regulatory documents indicate these ingredients help to stabilize the medicine, ensure proper dissolution and absorption in the body, preserve the medicine's shelf-life, and ensure the correct physical form (like a tablet or liquid) is manufactured.


Q: What is the general long-term expectation for people taking Pyrenol?

A: Pyrenol is officially intended for short-term, as-needed use to relieve symptoms of pain and fever. Regulatory documents caution that prolonged or regular daily use is associated with an increased risk of adverse events, particularly concerning the health of the liver, as detailed in regulatory warnings.


Q: Are there any known severe allergic reaction signs related to Pyrenol?

A: Yes, official warnings detail signs of a severe allergic reaction (hypersensitivity) that require immediate attention. These can include swelling of the face, mouth, or throat, difficulty breathing, or the appearance of severe skin reactions like rash, blistering, or skin peeling (known as Serious Skin Adverse Reactions or SSARs).


Q: Is Pyrenol affected by drinking caffeinated beverages?

A: Official drug information does not typically report a significant interaction between the active ingredient and external caffeinated beverages. However, some Pyrenol products contain caffeine as an adjuvant ingredient to enhance pain relief. Excessive caffeine intake from all sources (including the medicine itself and external drinks) may increase the risk of side effects like nervousness or headache.


Q: What are the differences between Pyrenol tablets and capsules?

A: Regulatory documents describe tablets as compressed solid forms that can sometimes be split, while capsules contain the medicine inside a shell that is typically swallowed whole. Both forms are designed to effectively deliver the medicine, but the capsule form may be associated with a slightly faster rate of absorption compared to some tablets.


Q: Does Pyrenol impact blood sugar levels?

A: Official product information indicates that the active ingredient in Pyrenol may interfere with certain laboratory tests used to measure glucose (blood sugar) levels. However, Pyrenol is not known to have a significant clinical interaction with most medicines prescribed for diabetes (insulin or oral hypoglycemic agents).


Q: Is it common for people to stop taking Pyrenol due to side effects?

A: Official data indicates that serious adverse events are reported only infrequently. The most commonly reported side effects, such as mild gastrointestinal upset or headache, are generally temporary. These common events often resolve on their own, and the data suggests discontinuation due to common side effects is infrequent.


Q: How does Pyrenol interact with common herbal supplements?

A: Since herbal remedies and supplements are not subject to the same rigorous testing as prescription or pharmacy medicines, official regulatory guidance generally advises consulting with a healthcare professional before combining the medicine with any herbal supplements. This measure is taken to address potential interaction effects, as these products are not subject to the same regulatory review.


Q: Is Pyrenol a medication that can cause dependence?

A: The active ingredient in Pyrenol alone is generally not associated with physical dependence or abuse potential in regulatory classifications. Because it is not an opioid, it is typically not regulated as a controlled substance for this reason. However, psychological reliance or needing higher doses over time (tolerance) may be reported in some contexts.

How should Pyrenol be stored and disposed of?

The storage and disposal instructions for Pyrenol (Paracetamol/Acetaminophen) are defined by regulatory requirements to maintain product stability and ensure safety.

Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Protection Keep away from excessive heat and moisture/humidity; protect from light.
Handling Liquid forms (suspensions/syrups) must not be frozen to prevent degradation.
Container/Safety Keep in the original, tightly closed container and out of the sight and reach of children.

Disposal Instructions

Unused or expired Pyrenol must be disposed of properly. The officially preferred method is to utilize a medicine take-back program or return the product to a pharmacist. Unless specifically instructed by regulatory guidance for the product, do not flush the medicine down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pyrenol found in:

A-Z Index: